Volume : 10, Issue : 04, April – 2023
Title:
25.DEVELOPMENT AND CHARACTERIZATION OF BUOYANT MICROSPHERES OF ZIDOVUDINE FOR TREATMENT OF VIRAL DISEASE
Authors :
Swati Ravindra Chaudhari , Arvind Pawara , Mayur Sharad Patel
Abstract :
Hollow buoyant microspheres of Zidovudine with Eudragit RS100 were successfully prepared by the oil in water emulsion solvent diffusion technique with better percentage yield. The problem associated with less Entrapment efficiency of drug in microspheres was overcome by modification of aqueous phase. The concentration of polymer also affected Buoyancy of microspheres in same proportionality. All the formulation exhibited excellent to good flow properties when evaluated for micromeritic properties. The drug release pattern was greatly affected by the concentration of polymer. The release was slower in the high polymer concentration formulation as compare to low polymer concentration formulations. The drug release of various formulations of microsphere was through Zero order model and drug release mechanism was through Non-Fickian case-II transport mechanism.
Cite This Article:
Please cite this article in press Mayur Sharad Patel et al, Development And Characterization Of Buoyant Microspheres Of Zidovudine For Treatment Of Viral Disease., Indo Am. J. P. Sci, 2023; 10 (04).
Number of Downloads : 10
References:
1. Mourya, D. T., Yadav, P. D., Ullas, P. T., Bhardwaj, S. D., Sahay, R. R., Chadha, M. S., Shete, A. M., Jadhav, S., Gupta, N., Gangakhedkar, R. R., Khasnobis, P., & Singh, S. K. (2019). Emerging/re-emerging viral diseases & new viruses on the Indian horizon. The Indian journal of medical research, 149(4), 447–467.
2. Selin JH, Pasrija PJ. Pharmacotherapy of Inflammatory Bowel Disease. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 11th edition. New York: McGraw Hill companies, Inc., USA; 2006. P. 1010.
3. Robinson, J., Vincent, H.L.L.; Controlled Drug Delivery Fundamentals and Applications, II Edn., Marcel Dekker, Inc, New york, 1968: 346-374.
4. Chien, Y.W.; Noval drug delivery system, II Edn., Marcel Dekker, New York, 1997; 50: 161-163.
5. Timmermans J, Moës AJ, “Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy”, J. Pharm Sci. 1994, 83, 1, 18-24.
6. Singh BN and Kim KH, “Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.” J. Control Rel. 2000, 63, 235–259.
7. Jain A. K., Jain C. P., Buoyant microspheres of famotidine: an approachable dosage form for gastric treatment, Journal of Young Pharm, 2009, 1 (1): 20-23.
8. Jain A. K., Jain C. P., Tanwar Y. S., Naruka P. S., Formulation, characterization and in vitro evaluation of floating microspheres of famotidine as a gastro retentive dosage form, Asian Journal of Pharmaceutics, 2009, 3 (3): 222-226.